The global sleep apnea devices market is estimated to be over US$ 4 Billion in 2017. It is anticipated to grow at a CAGR of 10.0% from 2019 to 2030.
The continual growth of the sleep apnea devices market can be attributed to several factors which have led to wide scale adoption of these products. Factors such as growing aging population and increase in lifestyle diseases like obesity, are further expected to contribute to the stable growth of the global sleep apnea devices market from 2019 to 2030. According to the National Healthy Sleep Awareness Project in 2015, it was revealed that obstructive sleep apnea affects more than 25 million people in the U.S. and it is a chronic disease that badly affects people. To obtain better insights regarding the market scenario, prominent players are increasingly focusing on collaborative initiatives with several institutes and research centers. For instance in 2018, Verily, a health data analytics company entered into an agreement with ResMed, a medical device manufacturer of sleep apnea. Both the companies have entered into a collaborative effort to study health and financial impacts of undiagnosed and untreated sleep apnea.
Top Players:
The prominent players in the global sleep apnea devices market are ResMed , Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, Compumedics Limited, DeVilbiss Healthcare LLC, BMC Medical Co., Ltd, VYAIRE, Curative Medical, Invacare Corporation and Somnetics International, Inc
No comments:
Post a Comment